望變電氣(603191.SH):預期2025年輸配電及控制設備出口訂單有望進一步提升
格隆匯12月23日丨望變電氣(603191.SH)披露投資者關係活動記錄表顯示,公司輸配電版塊在2024年開年以來,已先後簽訂多個出口項目合同,總金額近5000萬元;雲變2023年簽約3800多萬元出口馬來西亞653km馬東鐵路牽引變出口項目;集團出口產品包括鐵路專用牽引變、其他各型變壓器、高低壓智能成套開關櫃等,遍及馬來西亞、老撾、坦桑尼亞、斯里蘭卡等多個國家。
後期,公司輸配電及控制設備將以雲變為變壓器製造、研發、出海的基地。公司目前正在積極開拓目標區域市場,業務發展涉及東南亞、南亞、中東等政治友好地區,預期2025年輸配電及控制設備出口訂單有望進一步提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.